Oppenheimer Reiterates Outperform Rating on Inovio Pharmaceuticals (INO)

March 13, 2026 7:08 AM

Oppenheimer analyst Jay Olson reiterated an Outperform rating and $13.00 price target on Inovio Pharmaceuticals (NASDAQ: INO).The analyst comments "INO ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found